Survival outcomes in acute invasive fungal sinusitis: A systematic review and quantitative synthesis of published evidence

Laryngoscope

Volumn 123, Issue 5, 2013, Pages 1112-1118

  Turner, Justin H ^a   Soudry, Ethan ^b   Nayak, Jayakar V ^b   Hwang, Peter H ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

aspergillus; Invasive fungal sinusitis; mucor; mucormycosis; outcomes; survival

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; POSACONAZOLE; VORICONAZOLE;

ACUTE INVASIVE FUNGAL SINUSITIS; ARTICLE; COMORBIDITY; CRANIAL NERVE PARALYSIS; EAR NOSE THROAT SURGERY; EVIDENCE BASED MEDICINE; EXOPHTHALMOS; FACE EDEMA; FACE PAIN; FEVER; FUNGAL SINUSITIS; GROUPS BY AGE; HEADACHE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MENTAL HEALTH; MENTAL INSTABILITY; MOUTH ULCER; NOSE OBSTRUCTION; NOSE SECRETION; OPHTHALMOPLEGIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; SURVIVAL; SURVIVAL RATE; SYSTEMATIC REVIEW; SYSTEMIC MYCOSIS; TISSUE NECROSIS; VISUAL IMPAIRMENT; METHODOLOGY; MORTALITY; MYCOSIS; REVIEW; SINUSITIS; TREATMENT OUTCOME; UNITED STATES;

ANTIFUNGAL AGENTS; EVIDENCE-BASED MEDICINE; HUMANS; MYCOSES; SINUSITIS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

MLCS; MLOWN;

EID: 84879290732     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23912     Document Type: Article

References (57)

1. Gillespie MB, O'Malley BW Jr, Francis HW,. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg 1998; 124: 520-526.
2. Chen CY, Sheng WH, Cheng A, et al. Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan. BMC Infect Dis 2011; 11: 250.
3. Mohindra S, Mohindra S, Gupta R, Bakshi J, Gupta SK,. Rhinocerebral mucormycosis: the disease spectrum in 27 patients. Mycoses 2007; 50: 290-296.
4. Saedi B, Sadeghi M, Seilani P,. Endoscopic management of rhinocerebral mucormycosis with topical and intravenous amphotericin B. J Laryngol Otol 2011; 125: 807-810.
5. Khor BS, Lee MH, Leu HS, Liu JW,. Rhinocerebral mucormycosis in Taiwan. J Microbiol Immunol Infect 2003; 36: 266-269.
6. Sun HY, Forrest G, Gupta KL, et al. Rhino-orbital-cerebral zygomycosis in solid organ transplant recipients. Transplantation 2010; 90: 85-92.
7. Kara IO, Tasova Y, Uguz A, Sahin B,. Mucormycosis-associated fungal infections in patients with haematologic malignancies. Int J Clin Pract 2009; 63: 134-139.
8. Bhadada S, Bhansali A, Reddy KS, Bhat RV, Khandelwal N, Gupta AK,. Rhino-orbital-cerebral mucormycosis in type 1 diabetes mellitus. Indian J Pediatr 2005; 72: 671-674.
9. Dhiwakar M, Thakar A, Bahadur S,. Improving outcomes in rhinocerebral mucormycosis-early diagnostic pointers and prognostic factors. J Laryngol Otol 2003; 117: 861-865.
10. Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004; 80: 670-674.
11. Abbas Z, Jafri W, Rasool S, Abid S, Hameed I,. Mucormycosis in patients with complicated cirrhosis. Singapore Med J 2007; 48: 69-73.
12. Alobid I, Bernal M, Calvo C, Vilaseca I, Berenguer J, Alos L,. Treatment of rhinocerebral mucormycosis by combination of endoscopic sinus debridement and amphotericin B. Am J Rhinol 2001; 15: 327-331.
13. Anselmo-Lima WT, Lopes RP, Valera FC, Demarco RC,. Invasive fungal rhinosinusitis in immunocompromised patients. Rhinology 2004; 42: 141-144.
14. Bonifaz A, Macias B, Paredes-Farrera F, Arias P, Ponce RM, Araiza J,. Palatal zygomycosis: experience of 21 cases. Oral Dis 2008; 14: 569-574.
15. Butugan O, Sanchez TG, Goncalez F, Venosa AR, Miniti A,. Rhinocerebral mucormycosis: predisposing factors, diagnosis, therapy, complications and survival. Rev Laryngol Otol Rhinol (Bord) 1996; 117: 53-55.
16. Eliashar R, Resnick IB, Goldfarb A, Wohlgelernter J, Gross M,. Endoscopic surgery for sinonasal invasive aspergillosis in bone marrow transplantation patients. Laryngoscope 2007; 117: 78-81.
17. Godara SM, Kute VB, Goplani KR, et al. Mucormycosis in renal transplant recipients: predictors and outcome. Saudi J Kidney Dis Transpl 2011; 22: 751-756.
18. Guevara N, Roy D, Dutruc-Rosset C, Santini J, Hofman P, Castillo L,. Mucormycosis-early diagnosis and treatment. Rev Laryngol Otol Rhinol (Bord) 2004; 125: 127-131.
19. Hachem RY, Boktour MR, Hanna HA, et al. Sinus surgery combined with antifungal therapy is effective in the treatment of invasive Aspergillus sinusitis in neutropenic patients with cancer. Infection 2008; 36: 539-542.
20. Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001; 20: 460-466.
21. Hofman V, Castillo L, Betis F, Guevara N, Gari-Toussaint M, Hofman P,. Usefulness of frozen section in rhinocerebral mucormycosis diagnosis and management. Pathology 2003; 35: 212-216.
22. Hosseini SM, Borghei P,. Rhinocerebral mucormycosis: pathways of spread. Eur Arch Otorhinolaryngol 2005; 262: 932-938.
23. Howells RC, Ramadan HH,. Usefulness of computed tomography and magnetic resonance in fulminant invasive fungal rhinosinusitis. Am J Rhinol 2001; 15: 255-261.
24. Hunt SM, Miyamoto RC, Cornelius RS, Tami TA,. Invasive fungal sinusitis in the acquired immunodeficiency syndrome. Otolaryngol Clin North Am 2000; 33: 335-347.
25. Iwen PC, Rupp ME, Hinrichs SH,. Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature. Clin Infect Dis 1997; 24: 1178-1184.
26. Jiang RS, Hsu CY,. Endoscopic sinus surgery for rhinocerebral mucormycosis. Am J Rhinol 1999; 13: 105-109.
27. Johnson TE, Casiano RR, Kronish JW, Tse DT, Meldrum M, Chang W,. Sino-orbital aspergillosis in acquired immunodeficiency syndrome. Arch Ophthalmol 1999; 117: 57-64.
28. Jung SH, Kim SW, Park CS, et al. Rhinocerebral Mucormycosis: consideration of prognostic factors and treatment modality. Auris Nasus Larynx 2009; 36: 274-279.
29. Kasapoglu F, Coskun H, Ozmen OA, Akalin H, Ener B,. Acute invasive fungal rhinosinusitis: evaluation of 26 patients treated with endonasal or open surgical procedures. Otolaryngol Head Neck Surg 2010; 143: 614-620.
30. Ketenci I, Unlu Y, Kaya H, et al. Rhinocerebral mucormycosis: experience in 14 patients. J Laryngol Otol 2011; 125: e3.
31. Mbarek C, Zribi S, Khamassi K, et al. Rhinocerebral mucormycosis: five cases and a literature review. B-ENT 2011; 7: 189-193.
32. Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D'Souza O,. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 2003; 51: 231-236.
33. Parikh SL, Venkatraman G, DelGaudio JM,. Invasive fungal sinusitis: a 15-year review from a single institution. Am J Rhinol 2004; 18: 75-81.
34. Peterson KL, Wang M, Canalis RF, Abemayor E,. Rhinocerebral mucormycosis: evolution of the disease and treatment options. Laryngoscope 1997; 107: 855-862.
35. Pongbhaesaj P, Dejthevaporn C, Tunlayadechanont S, Witoonpanich R, Sungkanuparph S, Vibhagool A,. Aspergillosis of the central nervous system: a catastrophic opportunistic infection. Southeast Asian J Trop Med Public Health 2004; 35: 119-125.
36. Rangel-Guerra RA, Martinez HR, Saenz C, Bosques-Padilla F, Estrada-Bellmann I,. Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases. J Neurol Sci 1996; 143: 19-30.
37. Rassi SJ, Melkane AE, Rizk HG, Dahoui HA,. Sinonasal mucormycosis in immunocompromised pediatric patients. J Pediatr Hematol Oncol 2009; 31: 907-910.
38. Rizk SS, Kraus DH, Gerresheim G, Mudan S,. Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients. Ear Nose Throat J 2000; 79: 278-280, 282, 284-275.
39. Sahin B, Paydas S, Cosar E, Bicakci K, Hazar B,. Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. Eur J Clin Microbiol Infect Dis 1996; 15: 866-869.
40. Santos Gorjon P, Blanco Perez P, Batuecas Caletrio A, Munoz Herrera AM, Sanchez Gonzalez F, de la Fuente Canibano R,. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases. Acta Otorrinolaringol Esp 2010; 61: 48-53.
41. Scheckenbach K, Cornely O, Hoffmann TK, et al. Emerging therapeutic options in fulminant invasive rhinocerebral mucormycosis. Auris Nasus Larynx 2010; 37: 322-328.
42. Seiff SR, Choo PH, Carter SR,. Role of local amphotericin B therapy for sino-orbital fungal infections. Ophthal Plast Reconstr Surg 1999; 15: 28-31.
43. Shpitzer T, Stern Y, Anavi Y, Segal K, Feinmesser R,. Mucormycosis: experience with 10 patients. Clin Otolaryngol Allied Sci 1995; 20: 374-379.
44. Sohail MA, Al Khabori M, Hyder J, Verma A,. Acute fulminant fungal sinusitis: clinical presentation, radiological findings and treatment. Acta Trop 2001; 80: 177-185.
45. Sundaram C, Mahadevan A, Laxmi V, et al. Cerebral zygomycosis. Mycoses 2005; 48: 396-407.
46. Suslu AE, Ogretmenoglu O, Suslu N, Yucel OT, Onerci TM,. Acute invasive fungal rhinosinusitis: our experience with 19 patients. Eur Arch Otorhinolaryngol 2009; 266: 77-82.
47. Talmi YP, Goldschmied-Reouven A, Bakon M, et al. Rhino-orbital and rhino-orbito-cerebral mucormycosis. Otolaryngol Head Neck Surg 2002; 127: 22-31.
48. Talwalkar PG,. Rhino-occulo-cerebral mucormycosis in patients with type 2 diabetes mellitus. J Assoc Physicians India 2009; 57: 407-409.
49. Taxy JB, El-Zayaty S, Langerman A,. Acute fungal sinusitis: natural history and the role of frozen section. Am J Clin Pathol 2009; 132: 86-93.
50. Turunc T, Demiroglu YZ, Aliskan H, Colakoglu S, Arslan H,. Eleven cases of mucormycosis with atypical clinical manifestations in diabetic patients. Diabetes Res Clin Pract 2008; 82: 203-208.
51. Vener C, Carrabba M, Fracchiolla NS, et al. Invasive fungal sinusitis: an effective combined treatment in five haematological patients. Leukemia & lymphoma 2007; 48: 1577-1586.
52. Zappasodi P, Rossi M, Castagnola C, et al. Resolution of invasive fungal sinusitis in immunocompromised patients: neutrophil count is crucial beside a combined medical and surgical approach. Ann Hematol 2010; 89: 737-739.
53. Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG,. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg 2006; 22: 286-291.
54. Ramos ER, Jiang Y, Hachem R, Kassis C, Kontoyiannis DP, Raad I,. Outcome analysis of invasive aspergillosis in hematologic malignancy and hematopoietic stem cell transplant patients: the role of novel antimold azoles. Oncologist 2011; 16: 1049-1060.
55. Reuter S, Kern W, Zenz C, Kern P,. Prognostic factors for invasive aspergillosis in patients with haematological malignancies. Scand J Infect Dis 2009; 41: 483-490.
56. Gallien S, Fournier S, Porcher R, et al. Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases. Infection 2008; 36: 533-538.
57. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA,. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis 2007; 44: 531-540.